MENU
+Compare
INDP
Stock ticker: NASDAQ
AS OF
Mar 12, 03:32 PM (EDT)
Price
$0.84
Change
-$0.00 (-0.00%)
Capitalization
10.09M

INDP Indaptus Therapeutics Forecast, Technical & Fundamental Analysis

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more

INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for INDP with price predictions
Mar 11, 2025

INDP's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for INDP turned positive on February 26, 2025. Looking at past instances where INDP's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INDP's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on March 04, 2025. You may want to consider a long position or call options on INDP as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INDP advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INDP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INDP entered a downward trend on March 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.681) is normal, around the industry mean (11.839). P/E Ratio (0.000) is within average values for comparable stocks, (63.979). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.779). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (239.211).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INDP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INDP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INDP is expected to report earnings to rise 46.88% to -46 cents per share on March 13

Indaptus Therapeutics INDP Stock Earnings Reports
Q4'24
Est.
$-0.47
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.11
Q1'24
Beat
by $0.12
Q4'23
Beat
by $0.08
The last earnings report on November 12 showed earnings per share of -31 cents, beating the estimate of -47 cents. With 1.91K shares outstanding, the current market capitalization sits at 10.09M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AROC24.061.34
+5.90%
Archrock
POAI1.080.01
+0.93%
Predictive Oncology
PBI9.14-0.05
-0.54%
Pitney Bowes
ALTO1.40-0.01
-0.71%
Alto Ingredients
FDS431.17-11.74
-2.65%
Factset Research Systems

INDP and Stocks

Correlation & Price change

A.I.dvisor tells us that INDP and AFMD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDP and AFMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
+2.44%
AFMD - INDP
30%
Poorly correlated
-1.94%
SLNO - INDP
30%
Poorly correlated
+2.43%
VKTX - INDP
30%
Poorly correlated
-5.15%
ORMP - INDP
29%
Poorly correlated
+4.78%
AXON - INDP
28%
Poorly correlated
+2.17%
More